Mitochondrial diseases (MD) are heterogeneous disorders due to impairment of respiratory chain function leading to oxidative stress. We hypothesized that in MD the vascular endothelium may be affected by increased oxidative/nitrative stress causing a reduction of nitric oxide (NO) availability. We therefore, investigated the pathobiology of vasculature in MD patients by assaying the presence of 3-nitrotyrosine in muscle biopsies followed by the proteomic identification of proteins which undergo tyrosine nitration. We then measured the flow-mediated vasodilatation (FMD) as a proof of altered NO generation/bioactivity. Here, we show that 3-nitrotyrosine staining is specifically located in the small vessels of muscle tissue and that the reaction is stronger and more evident in a significant percentage of vessels from MD patients as compared to controls. Eleven specific proteins which are nitrated under pathological conditions were identified; most of them are involved in energy metabolism and are located mainly in mitochondria. In MD patients the FMD was reduced while baseline arterial diameters, blood flow velocity and endothelium-independent vasodilatation were similar to controls. The present results provide evidence that in MD the vessel wall is a target of increased oxidative/nitrative stress.

Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement.

VATTEMI, Gaetano Nicola;MARINI, Matteo;TONIN, PAOLA;MINUZ, Pietro;GUGLIELMI, Valeria;CHIAMULERA, Cristiano;MENEGUZZI, Alessandra;DI CHIO, Marzia;TEDESCO, Vincenzo;LOVATO, Laura;DEGAN, Maurizio;LECHI, Alessandro;TOMELLERI, Giuliano
2011-01-01

Abstract

Mitochondrial diseases (MD) are heterogeneous disorders due to impairment of respiratory chain function leading to oxidative stress. We hypothesized that in MD the vascular endothelium may be affected by increased oxidative/nitrative stress causing a reduction of nitric oxide (NO) availability. We therefore, investigated the pathobiology of vasculature in MD patients by assaying the presence of 3-nitrotyrosine in muscle biopsies followed by the proteomic identification of proteins which undergo tyrosine nitration. We then measured the flow-mediated vasodilatation (FMD) as a proof of altered NO generation/bioactivity. Here, we show that 3-nitrotyrosine staining is specifically located in the small vessels of muscle tissue and that the reaction is stronger and more evident in a significant percentage of vessels from MD patients as compared to controls. Eleven specific proteins which are nitrated under pathological conditions were identified; most of them are involved in energy metabolism and are located mainly in mitochondria. In MD patients the FMD was reduced while baseline arterial diameters, blood flow velocity and endothelium-independent vasodilatation were similar to controls. The present results provide evidence that in MD the vessel wall is a target of increased oxidative/nitrative stress.
2011
Protein nitration; Mitochondrial diseases; Vessel wall involvement
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/347088
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 37
social impact